{"id":"W4414710160","doi":"10.1016/j.esmoop.2025.105542","title":"Pembrolizumab with trastuzumab and chemotherapy for HER2-positive advanced gastric cancer: health-related quality-of-life analysis from the randomized KEYNOTE-811 trial","year":2025,"lang":"en","type":"article","venue":"ESMO Open","topic":"Gastric Cancer Management and Outcomes","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"ca_institutions":"Trinity College","funders":"National Cancer Institute; Astellas Pharma; Society for Anthropological Sciences; Merck Sharp and Dohme; Merck; MSD","keywords":"Pembrolizumab; Trastuzumab; Chemotherapy; Clinical trial; Randomized controlled trial; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008581635,0.001641367,0.003024699,0.0004134465,0.0003561068,0.001530192,0.0009079541,0.001633969,0.007299616],"category_scores_gemma":[0.006814015,0.0005357767,0.004376014,0.0005124125,0.0009750638,0.001260659,0.0009878131,0.0029132,0.0006358542],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001004302,"about_ca_system_score_gemma":0.00109628,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005489112,"about_ca_topic_score_gemma":0.001041078,"domain_scores_codex":[0.9944149,0.004239113,0.0003079333,0.0004580076,0.0002829103,0.0002969785],"domain_scores_gemma":[0.9973307,0.0009180701,0.0008927578,0.000304279,0.0001675265,0.0003867726],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.984724,0.000914296,0.0009476041,0.001006988,0.003995307,0.00002362889,0.00001964821,0.0004417487,0.0006967674,0.0001155767,0.0007010733,0.006413287],"study_design_scores_gemma":[0.9629173,0.02555904,0.004279617,0.0001486976,0.004806395,0.00005998271,0.00002443041,0.0005365214,0.0002747693,0.0003639288,0.001009618,0.0000196697],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.953389,0.02449207,0.002387602,0.001935114,0.0008197,0.007494913,0.005077758,0.0001578162,0.004245973],"genre_scores_gemma":[0.9798492,0.003573587,0.001894363,0.001361623,0.0004713103,0.007252775,0.003792116,0.00003048747,0.001774564],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.008581635,"threshold_uncertainty_score":0.04538459,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02730956368770292,"score_gpt":0.3591426641774245,"score_spread":0.3318331004897216,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}